Skip to main content

Inovio closes $173M public stock sale to fund Covid-19 vaccine development

The company is conducting mid-stage testing of a Covid-19 vaccine candidate.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.